« Back
Home /
Anti-PDL1 (atezolizumab biosimilar) mAb

Anti-PDL1 (atezolizumab biosimilar) mAb

Manufacturer	DIMA Biotechnology
Category	Oncology Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Melanoma Sarcoma Myelofibrosis Mesothelioma Flow Cytometry ELISA Primary Antibodies
Type	Antibody Monoclonal
Specific against	Human
Isotype	IgG1
Format	Liquid
Applications	ELISA, Flow cytometry
Amount	50 ul
Host	Humanized
Item no.	DIM-BME100009-50ul
Targets	CD274;;CD279
eClass 6.1	32160702
eClass 9.0	42030590
Available
Storage	Store at -20C (Avoid repeated freezing and thawing)
Usage	Research use only
Clonality	Monoclonal
Buffer	Preservative: 0.1% Procline 300 Constituents: 50% Glycerol; PBS, pH 7.4; 0.1% BSA
Purification	Purified from cell culture supernatant by affinity chromatography
Recommended Dilutions	ELISA 1:5000-10000
Guarantee	12 months from date of despatch
Shipping	Ice pack
Note	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 ul

available

Delivery expected until 7/4/2024